Acrivon Therapeutics Common Stock Market Value
| ACRV Stock | 7.72 0.23 2.89% |
| Symbol | Acrivon |
Acrivon Therapeutics Price To Book Ratio
Is Acrivon Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acrivon Therapeutics. If investors know Acrivon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acrivon Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.89) | Return On Assets (0.30) | Return On Equity (0.48) |
The market value of Acrivon Therapeutics is measured differently than its book value, which is the value of Acrivon that is recorded on the company's balance sheet. Investors also form their own opinion of Acrivon Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Acrivon Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acrivon Therapeutics' market value can be influenced by many factors that don't directly affect Acrivon Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acrivon Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acrivon Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acrivon Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Acrivon Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acrivon Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acrivon Therapeutics.
| 02/29/2024 |
| 05/29/2024 |
If you would invest 0.00 in Acrivon Therapeutics on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding Acrivon Therapeutics Common or generate 0.0% return on investment in Acrivon Therapeutics over 90 days. Acrivon Therapeutics is related to or competes with Transcode Therapeutics, MicroAlgo, Morningstar Unconstrained, T Rowe, Nt International, Malaga Financial, and Americold Realty. Acrivon Therapeutics is entity of United States More
Acrivon Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acrivon Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acrivon Therapeutics Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.38 | |||
| Information Ratio | 0.1376 | |||
| Maximum Drawdown | 73.69 | |||
| Value At Risk | (10.84) | |||
| Potential Upside | 18.2 |
Acrivon Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acrivon Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acrivon Therapeutics' standard deviation. In reality, there are many statistical measures that can use Acrivon Therapeutics historical prices to predict the future Acrivon Therapeutics' volatility.| Risk Adjusted Performance | 0.0921 | |||
| Jensen Alpha | 1.47 | |||
| Total Risk Alpha | 1.07 | |||
| Sortino Ratio | 0.237 | |||
| Treynor Ratio | 0.616 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acrivon Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acrivon Therapeutics Backtested Returns
Acrivon Therapeutics is relatively risky given 3 months investment horizon. Acrivon Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.22% are justified by taking the suggested risk. Use Acrivon Therapeutics Mean Deviation of 7.03, downside deviation of 6.38, and Risk Adjusted Performance of 0.0921 to evaluate company specific risk that cannot be diversified away. Acrivon Therapeutics holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.5, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Acrivon Therapeutics will likely underperform. Use Acrivon Therapeutics value at risk, as well as the relationship between the kurtosis and price action indicator , to analyze future returns on Acrivon Therapeutics.
Auto-correlation | -0.62 |
Very good reverse predictability
Acrivon Therapeutics Common has very good reverse predictability. Overlapping area represents the amount of predictability between Acrivon Therapeutics time series from 29th of February 2024 to 14th of April 2024 and 14th of April 2024 to 29th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acrivon Therapeutics price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Acrivon Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.51 |
Acrivon Therapeutics lagged returns against current returns
Autocorrelation, which is Acrivon Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Acrivon Therapeutics' stock expected returns. We can calculate the autocorrelation of Acrivon Therapeutics returns to help us make a trade decision. For example, suppose you find that Acrivon Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Acrivon Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Acrivon Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Acrivon Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Acrivon Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Acrivon Therapeutics Lagged Returns
When evaluating Acrivon Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Acrivon Therapeutics stock have on its future price. Acrivon Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Acrivon Therapeutics autocorrelation shows the relationship between Acrivon Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Acrivon Therapeutics Common.
Regressed Prices |
| Timeline |
Pair Trading with Acrivon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acrivon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Acrivon Stock
| 0.88 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.88 | ALKS | Alkermes Plc | PairCorr |
| 0.81 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.8 | GILD | Gilead Sciences | PairCorr |
| 0.8 | CYTH | Cyclo Therapeutics | PairCorr |
The ability to find closely correlated positions to Acrivon Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acrivon Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acrivon Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acrivon Therapeutics Common to buy it.
The correlation of Acrivon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acrivon Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acrivon Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acrivon Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Acrivon Therapeutics Correlation, Acrivon Therapeutics Volatility and Acrivon Therapeutics Alpha and Beta module to complement your research on Acrivon Therapeutics. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Acrivon Stock analysis
When running Acrivon Therapeutics' price analysis, check to measure Acrivon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics is operating at the current time. Most of Acrivon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics' price. Additionally, you may evaluate how the addition of Acrivon Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Acrivon Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.